From Pacific Research Institute <[email protected]>
Subject Read about Biden's latest attack on medical innovation
Date December 20, 2023 8:59 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
PRI's Focus on Health Care

View this email in your browser ([link removed])
[link removed]
The Biden Administration Abuses Inflation to Attack Medical Innovation
Right by the Bay | Wayne Winegarden | December 19, 2023

In another assault on drug innovation, the Biden Administration has “announced ([link removed]) ” “that it will require dozens of pharmaceutical companies to pay rebates to Medicare after hiking drug prices more rapidly than inflation in 2023.” This policy is theoretically bankrupt and pragmatically destructive.

Read here . . . ([link removed])
How 2024 Republican presidential candidates should talk about healthcare
Washington Examiner | Sally C. Pipes | December 15, 2023

The U.S. healthcare system is in need of reform. And voters are rejecting the government-dominated ideas that Democrats are offering up. Republicans must be specific about how market-oriented reforms can deliver what voters are looking for.

Read more... ([link removed])

------------------------------------------------------------

Reigning in the true culprit behind critical medicine shortages
Fort Meyers News-Press | Sally C. Pipes | December 17, 2023

Drug shortages in the United States have reached crisis levels. The Food and Drug Administration reports that nearly 140 medicines are currently in short supply. That figure includes more than a dozen cancer drugs, which has forced doctors and patients to confront the dangerous possibility of rationing.

Read more... ([link removed])
[link removed]

============================================================
** Twitter ([link removed])
** Facebook ([link removed])
** YouTube ([link removed])
** LinkedIn ([link removed])
** Website ([link removed])
Copyright © 2022 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
P.O. Box 60485 Pasadena, CA 91116

** ([link removed])

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.
Screenshot of the email generated on import

Message Analysis